2022
DOI: 10.1111/clr.13964
|View full text |Cite
|
Sign up to set email alerts
|

The effect of the use of proton pump inhibitors, serotonin uptake inhibitors, antihypertensive, and anti‐inflammatory drugs on clinical outcomes of functional dental implants: A retrospective study

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 53 publications
0
7
0
Order By: Relevance
“…The smoking status was assessed at the time of first implant placement, through a questionnaire. Following a previous study [ 27 ], the periodontal status was assessed before the implant placement and during each follow-up visit by following the criteria by Tonetti et al [ 28 ]. site-related factors: implant location prosthesis-related factors (to be evaluated using the radiographs taken after placement of the prosthesis): prosthesis type (single crown or partial fixed denture), fixation methods (screwed or cemented), platform switching, crown height (I-CH), extension of prosthetic cantilever (only for single-tooth restorations) (mesial and / or distal) (C-M, C-D), angle of emergence profile (mesial and distal) (C-M-EP, C-D-EP) which is calculated as the angle between the implant axis and the line tangent to the prosthetic crown [ 18 ], presence of misfit between the prosthesis itself and the abutment.…”
Section: Methodsmentioning
confidence: 99%
“…The smoking status was assessed at the time of first implant placement, through a questionnaire. Following a previous study [ 27 ], the periodontal status was assessed before the implant placement and during each follow-up visit by following the criteria by Tonetti et al [ 28 ]. site-related factors: implant location prosthesis-related factors (to be evaluated using the radiographs taken after placement of the prosthesis): prosthesis type (single crown or partial fixed denture), fixation methods (screwed or cemented), platform switching, crown height (I-CH), extension of prosthetic cantilever (only for single-tooth restorations) (mesial and / or distal) (C-M, C-D), angle of emergence profile (mesial and distal) (C-M-EP, C-D-EP) which is calculated as the angle between the implant axis and the line tangent to the prosthetic crown [ 18 ], presence of misfit between the prosthesis itself and the abutment.…”
Section: Methodsmentioning
confidence: 99%
“…Altay et al [ 1 ] reported negative effect on EIF in PPI users. Conversely, Corbella et al [ 18 ] reported that the use of PPIs, appeared to have no influence on implant survival.…”
Section: Discussionmentioning
confidence: 99%
“…331 Another recent retrospective study 332 found that patients using nonsteroidal anti-inflammatory drugs (NSAIDs) presented significantly higher levels of peri-implantitis than control patients, whereas the researchers did not find an influence on implant survival or an augmented risk of peri-implantitis in patients taking SSRI drugs, proton pump inhibitors, or antihypertensive medications. 332 The authors concluded regarding SSRIs that even when the association between SSRIs and implant failure or peri-implantitis is biologically plausible, there is a need for more research to confirm these findings. 332 As stated above, serotonin can regulate osteoblast/osteoclast balance and so SSRIs may modify the activation and differentiation of osteoclasts 315 and reduce osteoblast differentiation and mineralization.…”
Section: Selectiveserotoninreuptakeinhibitorsmentioning
confidence: 99%
“…332 The authors concluded regarding SSRIs that even when the association between SSRIs and implant failure or peri-implantitis is biologically plausible, there is a need for more research to confirm these findings. 332 As stated above, serotonin can regulate osteoblast/osteoclast balance and so SSRIs may modify the activation and differentiation of osteoclasts 315 and reduce osteoblast differentiation and mineralization. 326 This negative impact on bone metabolism regulation was verified by a reduction of osteoblast marker genes like alkaline phosphatase, osteocalcin, and Osterix.…”
Section: Selectiveserotoninreuptakeinhibitorsmentioning
confidence: 99%